HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tomasello, S. Search for Related Content PubMed Articles by Tomasello, S. Related Collections Related Article Social Bookmarking                What's this?

Secondary Hyperparathyroidism and Chronic Kidney Disease

In Brief

Secondary hyperparathyroidism (SHPT) describes a complex alteration in bone and mineral metabolism that occurs as a direct result of chronic kidney disease (CKD). Bone disease, a well-recognized complication of SHPT, represents only a small concern in light of the evidence that correlates SHPT with cardiovascular disease and an increased risk of morbidity and mortality in patients with CKD. Patients with mild CKD may be asymptomatic and therefore may not be identified until the pathology of SHPT has begun. Identifying patients at risk and evaluating for SHPT is imperative because early intervention may slow or arrest the progression of both bone and cardiac disease. Dietary concerns, pharmacotherapy, and patient adherence are all important considerations in creating a successful treatment plan.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article:

Diabetic Kidney Disease: Chronic Kidney Disease and Diabetes

Jerry Yee
Diabetes Spectr 2008 21: 8-10. [Extract] [Full Text] [PDF]